文献速递产科母胎医学

三维容积渲染超声评估胎盘植入谱系疾病严重程度并鉴别单纯瘢痕裂开

Three-dimensional volume rendering ultrasound for assessing placenta accreta spectrum severity and discriminating it from simple scar dehiscence.
PubMed 文献 · Am J Obstet Gynecol MFM · 2024-03-07

前瞻性队列研究纳入70例既往剖宫产、前置胎盘或低置胎盘疑诊胎盘植入谱系疾病的孕妇,评估三维容积渲染超声鉴别胎盘植入谱系疾病与瘢痕裂开及判断严重程度的价值。三维清晰带消失鉴别两者的曲线下面积为0.911,灵敏度89.3%、特异度92.9%。

要点

  • 三维清晰带消失鉴别瘢痕裂开与胎盘植入谱系疾病的曲线下面积为0.911。
  • 二维多普勒桥接血管鉴别两者的曲线下面积为0.848,灵敏度91.1%、特异度78.6%。
  • 三维膀胱浆膜中断伴膀胱子宫间隙消失与膀胱子宫粘连相关(P<.001)。

核心结论

  • 三维容积渲染超声有望有效鉴别瘢痕裂开伴下方非粘连胎盘与胎盘植入谱系疾病。
  • 三维容积渲染超声在预测胎盘植入谱系疾病膀胱受累的临床严重程度方面也显示出潜力。

研究设计与样本

  • 前瞻性队列研究,于2022年7月至2023年7月在印度尼西亚泗水Dr Soetomo学术综合医院胎儿医学部开展。
  • 共纳入70例孕妇,其中胎盘植入谱系疾病56例、瘢痕裂开14例。
  • 纳入既往剖宫产且本次为前壁低置胎盘或前置胎盘、转诊疑诊胎盘植入谱系疾病的孕妇,先行标准化二维及多普勒超声筛查,再于膀胱充盈状态下取子宫矢状面获取三维容积。

主要发现

  • 多因素logistic回归显示,三维清晰带消失(P<.001)与二维多普勒桥接血管(P=.027)是鉴别瘢痕裂开与胎盘植入谱系疾病的优良预测指标。
  • 三维清晰带消失的曲线下面积为0.911(95%CI 0.819-1.002),灵敏度89.3%(95%CI 78.1-95.97%),特异度92.9%(95%CI 66.1-99.8%)。
  • 二维多普勒桥接血管的曲线下面积为0.848(95%CI 0.714-0.982),灵敏度91.1%(95%CI 80.4-97.0%),特异度78.6%(95%CI 49.2-95.3%)。
  • 胎盘植入谱系疾病组内亚组分析显示,三维膀胱浆膜中断伴膀胱子宫间隙消失与膀胱子宫粘连相关(P<.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Prenatal ultrasound discrimination between placenta accreta spectrum and scar dehiscence with underlying nonadherent placenta is challenging both prenatally and intraoperatively, which often leads to overtreatment. In addition, accurate prenatal prediction of surgical difficulty and morbidity in placenta accreta spectrum is difficult, which precludes appropriate multidisciplinary planning. The advent of advanced 3-dimensional volume rendering and contrast enhancement techniques in modern ultrasound systems provides a comprehensive prenatal assessment, revealing details that are not discernible in traditional 2-dimensional imaging. OBJECTIVE: This study aimed to evaluate the use of 3-dimensional volume rendering ultrasound techniques in determining the severity of placenta accreta spectrum and distinguishing between placenta accreta spectrum and scar dehiscence with underlying nonadherent placenta. STUDY DESIGN: A prospective, cohort study was conducted between July 2022 and July 2023 in the fetal medicine unit of Dr Soetomo Academic General Hospital, Surabaya, Indonesia. All pregnant individuals with anterior low-lying placenta or placenta previa with a previous caesarean section who were referred with suspicion of placenta accreta spectrum were consented and screened using the standardised 2-dimensional and Doppler ultrasound imaging. Additional 3-dimensional volumes were obtained from the sagittal section of the uterus with a filled urinary bladder. These were analyzed by rotating the region of interest to be perpendicular to the uterovesical interface. The primary outcomes were the clinical and histologic severity in the cases of placenta accreta spectrum and correct diagnosis of dehiscence with nonadherent placenta underneath. The strength of association between ultrasound and clinical outcomes was determined. Multivariate logistic regression analyses and diagnostic testing of accuracy were used to analyze the data. RESULTS: A total of 70 patients (56 with placenta accreta spectrum and 14 with scar dehiscence) were included in the analysis. Multivariate logistic regression of all 2-dimensional and 3-dimensional signs revealed the 3-dimensional loss of clear zone (P<.001) and the presence of bridging vessels on 2-dimensional Doppler ultrasound (P=.027) as excellent predictors in differentiating scar dehiscence and placenta accreta spectrum. The 3-dimensional loss of clear zone demonstrated a high diagnostic accuracy with an area under the curve of 0.911 (95% confidence interval, 0.819-1.002), with a sensitivity of 89.3% (95% confidence interval, 78.1-95.97%) and specificity of 92.9% (95% confidence interval, 66.1-99.8%). The presence of bridging vessels on 2-dimensional Doppler demonstrated an area under the curve of 0.848 (95% confidence interval, 0.714-0.982) with a sensitivity of 91.1% (95% confidence interval, 80.4-97.0%) and specificity of 78.6% (95% confidence interval, 49.2-95.3%). A subgroup analysis among the placenta accreta spectrum group revealed that the presence of a 3-dimensional disrupted bladder serosa with obliteration of the vesicouterine space was associated with vesicouterine adherence (P<.001). CONCLUSION: Three-dimensional volume rendering ultrasound is a promising tool for effective discrimination between scar dehiscence with underlying nonadherent placenta and placenta accreta spectrum. It also shows potential in predicting the clinical severity with urinary bladder involvement in cases of placenta accreta spectrum.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Adu-Bredu TK, Ridwan R, Aditiawarman A, et al. Three-dimensional volume rendering ultrasound for assessing placenta accreta spectrum severity and discriminating it from simple scar dehiscence. Am J Obstet Gynecol MFM. 2024. PMID: 38460827. doi:10.1016/j.ajogmf.2024.101321

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。